Fund Holdings — BROADWOOD CAPITAL INC

Total Portfolio Value
$1.33B
Total Bought
$108.06M
Total Sold
$3.93M
Net Transaction
+$104.14M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
STAAR SURGICAL CO(STAA)10,537,83510,768,430+230,595328,886412,21630.97%+83,330
AXON ENTERPRISE INC(AXON)760,062760,0620196,347237,80817.87%+41,461
LINEAGE CELL THERAPEUTICS IN(LCTX)34,935,48541,666,255+6,730,77038,08061,6664.63%+23,586
ISHARES TR566,000566,0000113,602119,0308.94%+5,428
MONSTER BEVERAGE CORP NEW(MNST)8,488,0178,295,690-192,327488,995491,76936.95%+2,774
SERINA THERAPEUTICS INC(SER)085,219+85,21901,1470.09%+1,147
ONCOCYTE CORP(IMDX)2,509,0662,509,06606,2737,3520.55%+1,079
AGEX THERAPEUTICS INC2,997,1560-2,997,1561,1540—-1,154
Page 1 of 1
BROADWOOD CAPITAL INC — 13F Holdings — Q1 2024 | TickerTrail